BACKGROUND. Exercise is a common stimulus of bronchoconstriction in subjects with asthma, who also have bronchoconstriction after inhaling the sulfidopeptide leukotriene D4 (LTD4). The purpose of this study was to investigate the importance of LTD4 as a mediator of exercise-induced bronchoconstriction. METHODS. In a double-blind, randomized, crossover study, 12 subjects with stable asthma were treated intravenously with MK-571 (160 mg), a selective and potent LTD4-receptor antagonist, or placebo, 20 minutes before each of two challenges involving exercise at a level previously demonstrated to cause a fall of at least 20 percent in the forced expiratory volume in one second (FEV1). The two exercise challenges were separated by one week. The results of the challenges were expressed as both the maximal fall in FEV1 after exercise and the time to recovery from bronchoconstriction. RESULTS. Treatment with MK-571 attenuated exercise-induced bronchoconstriction in all the subjects. The mean (+/- SEM) maximal percent decrease in FEV1 after exercise was 25.2 +/- 3.5 percent in the subjects taking placebo and 9.2 +/- 2.5 percent in the subjects taking MK-571 (P less than 0.001). The mean percent inhibition for the entire group was 69.5 percent. The mean time to recovery after exercise was 33.4 +/- 4.0 minutes in the placebo group and 8.4 +/- 2.5 minutes in the MK-571 group (P less than 0.001). CONCLUSIONS. This study demonstrates that pretreatment with a potent and selective LTD4 antagonist markedly attenuates exercise-induced bronchoconstriction, and it suggests that LTD4 is a major mediator of this type of bronchoconstriction.
Source Information
Department of Medicine, McMaster University, Hamilton, Ont., Canada.
This article has been cited by other articles:
Kaetsu, Y., Yamamoto, Y., Sugihara, S., Matsuura, T., Igawa, G., Matsubara, K., Igawa, O., Shigemasa, C., Hisatome, I.
(2007). Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro. Cardiovasc Res
76: 160-166
[Abstract][Full Text]
Philip, G., Pearlman, D. S., Villaran, C., Legrand, C., Loeys, T., Langdon, R. B., Reiss, T. F.
(2007). Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction. Chest
132: 875-883
[Abstract][Full Text]
Kim, D. C., Hsu, F. I., Barrett, N. A., Friend, D. S., Grenningloh, R., Ho, I-C., Al-Garawi, A., Lora, J. M., Lam, B. K., Austen, K. F., Kanaoka, Y.
(2006). Cysteinyl Leukotrienes Regulate Th2 Cell-Dependent Pulmonary Inflammation. J. Immunol.
176: 4440-4448
[Abstract][Full Text]
Casas, A., Gomez, F. P., Dahlen, B., Roca, J., Barbera, J. A., Dahlen, S-E., Rodriguez-Roisin, R.
(2005). Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor. Eur Respir J
26: 442-448
[Abstract][Full Text]
Coreno, A., Skowronski, M., West, E., El-Ekiaby, A., McFadden, E.R. Jr
(2005). Bronchoprotective Effects of Single Doses of Salmeterol Combined With Montelukast in Thermally Induced Bronchospasm. Chest
127: 1572-1578
[Abstract][Full Text]
Rundell, K W, Spiering, B A, Baumann, J M, Evans, T M
(2005). Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Br. J. Sports. Med.
39: 232-236
[Abstract][Full Text]
Beller, T. C., Maekawa, A., Friend, D. S., Austen, K. F., Kanaoka, Y.
(2004). Targeted Gene Disruption Reveals the Role of the Cysteinyl Leukotriene 2 Receptor in Increased Vascular Permeability and in Bleomycin-induced Pulmonary Fibrosis in Mice. J. Biol. Chem.
279: 46129-46134
[Abstract][Full Text]
Beller, T. C., Friend, D. S., Maekawa, A., Lam, B. K., Austen, K. F., Kanaoka, Y.
(2004). Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl. Acad. Sci. USA
101: 3047-3052
[Abstract][Full Text]
Mickleborough, T. D., Murray, R. L., Ionescu, A. A., Lindley, M. R.
(2003). Fish Oil Supplementation Reduces Severity of Exercise-induced Bronchoconstriction in Elite Athletes. Am. J. Respir. Crit. Care Med.
168: 1181-1189
[Abstract][Full Text]
Brannan, J.D., Gulliksson, M., Anderson, S.D., Chew, N., Kumlin, M.
(2003). Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J
22: 491-496
[Abstract][Full Text]
Green, R H, Brightling, C E, Pavord, I D, Wardlaw, A J
(2003). Management of asthma in adults: current therapy and future directions. Postgrad. Med. J.
79: 259-267
[Abstract][Full Text]
Freed, A. N., McCulloch, S., Meyers, T., Suzuki, R.
(2003). Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways. Am. J. Respir. Crit. Care Med.
167: 1102-1108
[Abstract][Full Text]
Terashima, T., Amakawa, K., Matsumaru, A., Yamaguchi, K.
(2002). Correlation Between Cysteinyl Leukotriene Release From Leukocytes and Clinical Response to a Leukotriene Inhibitor. Chest
122: 1566-1570
[Abstract][Full Text]
Maekawa, A., Austen, K. F., Kanaoka, Y.
(2002). Targeted Gene Disruption Reveals the Role of Cysteinyl Leukotriene 1 Receptor in the Enhanced Vascular Permeability of Mice Undergoing Acute Inflammatory Responses. J. Biol. Chem.
277: 20820-20824
[Abstract][Full Text]
Salvi, S. S., Krishna, M. T., Sampson, A. P., Holgate, S. T.
(2001). The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma. Chest
119: 1533-1546
[Abstract][Full Text]
BRANNAN, J. D., ANDERSON, S. D., GOMES, K., KING, G. G., KIM CHAN, H., PAUL SEALE, J.
(2001). Fexofenadine Decreases Sensitivity to and Montelukast Improves Recovery from Inhaled Mannitol. Am. J. Respir. Crit. Care Med.
163: 1420-1425
[Abstract][Full Text]
Dahlen, B., O'Byrne, P.M., Watson, R.M., Roquet, A., Larsen, F., Inman, M.D.
(2001). The reproducibility and sample size requirements of exercise-induced bronchoconstriction measurements. Eur Respir J
17: 581-588
[Abstract][Full Text]
Suman, O. E., Beck, K. C.
(2001). Role of nitric oxide during hyperventilation-induced bronchoconstriction in the guinea pig. J. Appl. Physiol.
90: 1474-1480
[Abstract][Full Text]
De Gouw, H. W. F. M., Marshall-Partridge, S. J., Van der Veen, H., Van den Aardweg, J. G., Hiemstra, P. S., Sterk, P. J.
(2001). Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects. J. Appl. Physiol.
90: 586-592
[Abstract][Full Text]
Bisgaard, H.
(2001). Leukotriene Modifiers in Pediatric Asthma Management. Pediatrics
107: 381-390
[Abstract][Full Text]
Freed, A. N., McCulloch, S., Wang, Y.
(2000). Eicosanoid and muscarinic receptor blockade abolishes hyperventilation-induced bronchoconstriction. J. Appl. Physiol.
89: 1949-1955
[Abstract][Full Text]
Suman, O. E., Morrow, J. D., O'Malley, K. A., Beck, K. C.
(2000). Airway function after cyclooxygenase inhibition during hyperpnea-induced bronchoconstriction in guinea pigs. J. Appl. Physiol.
89: 1971-1978
[Abstract][Full Text]
GAUVREAU, G. M., RONNEN, G. M., WATSON, R. M., O'BYRNE, P. M.
(2000). Exercise-induced Bronchoconstriction Does Not Cause Eosinophilic Airway Inflammation or Airway Hyperresponsiveness in Subjects with Asthma. Am. J. Respir. Crit. Care Med.
162: 1302-1307
[Abstract][Full Text]
CHRISTIAN VIRCHOW, J. Jr., PRASSE, A., NAYA, I., SUMMERTON, L., HARRIS, A., The Zafirlukast Study Group,
(2000). Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids. Am. J. Respir. Crit. Care Med.
162: 578-585
[Abstract][Full Text]
SUZUKI, R., FREED, A. N.
(2000). Heparin Inhibits Eicosanoid Metabolism and Hyperventilation-induced Bronchoconstriction in Dogs. Am. J. Respir. Crit. Care Med.
161: 1850-1854
[Abstract][Full Text]
Dockhorn, R J, Baumgartner, R A, Leff, J A, Noonan, M, Vandormael, K, Stricker, W, Weinland, D E, Reiss, T F
(2000). Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax
55: 260-265
[Abstract][Full Text]
O'BYRNE, P. M.
(2000). Why Does Airway Inflammation Persist? Is It Leukotrienes?. Am. J. Respir. Crit. Care Med.
161: S186-187
[Full Text]
RODGER, I. W.
(2000). From Bench to Bedside . The Hurdles of Discovering a New Leukotriene Receptor Antagonist. Am. J. Respir. Crit. Care Med.
161: S7-10
[Full Text]
LAM, B. K., FRANK AUSTEN, K.
(2000). Leukotriene C4 Synthase . A Pivotal Enzyme in the Biosynthesis of the Cysteinyl Leukotrienes. Am. J. Respir. Crit. Care Med.
161: S16-19
[Full Text]
O'BYRNE, P. M.
(2000). Leukotriene Bronchoconstriction Induced by Allergen and Exercise. Am. J. Respir. Crit. Care Med.
161: S68-72
[Full Text]
KUMLIN, M.
(2000). Measurement of Leukotrienes in Humans. Am. J. Respir. Crit. Care Med.
161: S102-106
[Full Text]
Edelman, J. M., Turpin, J. A., Bronsky, E. A., Grossman, J., Kemp, J. P., Ghannam, A. F., DeLucca, P. T., Gormley, G. J., Pearlman, D. S., for the Exercise Study Group*,
(2000). Oral Montelukast Compared with Inhaled Salmeterol To Prevent Exercise-Induced Bronchoconstriction: A Randomized, Double-Blind Trial. ANN INTERN MED
132: 97-104
[Abstract][Full Text]
FUJIMURA, M., ABO, M., KAMIO, Y., MYOU, S., ISHIURA, Y., HASHIMOTO, T., MATSUDA, T.
(1999). Effect of Leukotriene and Thromboxane Antagonist on Propranolol-induced Bronchoconstriction. Am. J. Respir. Crit. Care Med.
160: 2100-2103
[Abstract][Full Text]
Freed, A. N., Wang, Y., McCulloch, S., Myers, T., Suzuki, R.
(1999). Mucosal injury and eicosanoid kinetics during hyperventilation-induced bronchoconstriction. J. Appl. Physiol.
87: 1724-1733
[Abstract][Full Text]
(1999). Leukotriene-receptor antagonists and related compounds. CMAJ
161: s31-34
[Full Text]
AHMED, T., GONZALEZ, B. J., DANTA, I.
(1999). Prevention of Exercise-induced Bronchoconstriction by Inhaled Low-molecular-weight Heparin. Am. J. Respir. Crit. Care Med.
160: 576-581
[Abstract][Full Text]
Matsumoto, I, Araki, H, Tsuda, K, Odajima, H, Nishima, S, Higaki, Y, Tanaka, H, Tanaka, M, Shindo, M
(1999). Effects of swimming training on aerobic capacity and exercise induced bronchoconstriction in children with bronchial asthma. Thorax
54: 196-201
[Abstract][Full Text]
Drazen, J. M., Israel, E., O'Byrne, P. M.
(1999). Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. NEJM
340: 197-206
[Full Text]
Yang, X. X., Powell, W. S., Xu, L. J., Martin, J. G.
(1999). Strain dependence of the airway response to dry-gas hyperpnea challenge in the rat. J. Appl. Physiol.
86: 152-158
[Abstract][Full Text]
Wenzel, S. E.
(1998). Antileukotriene Drugs in the Management of Asthma. JAMA
280: 2068-2069
[Full Text]
Barnes, P. J., Chung, K. F., Page, C. P.
(1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev.
50: 515-596
[Abstract][Full Text]
DRAZEN, J. M.
(1998). Leukotrienes as Mediators of Airway Obstruction. Am. J. Respir. Crit. Care Med.
158: S193-S200
[Abstract][Full Text]
Leff, J. A., Busse, W. W., Pearlman, D., Bronsky, E. A., Kemp, J., Hendeles, L., Dockhorn, R., Kundu, S., Zhang, J., Seidenberg, B. C., Reiss, T. F.
(1998). Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction. NEJM
339: 147-152
[Abstract][Full Text]
Freed, A. N., Taskar, V., Schofield, B., Omori, C.
(1997). Hyperventilation-induced airway injury and vascular leakage in dogs: effects of alpha 1-adrenergic agonists. J. Appl. Physiol.
83: 1884-1889
[Abstract][Full Text]
HORWITZ, R. J., MCGILL, K. A., BUSSE, W. W.
(1997). The Role of Leukotriene Modifiers in the Treatment of Asthma. Am. J. Respir. Crit. Care Med.
157: 1363-1371
[Full Text]
Yang, X. X., Powell, W. S., Hojo, M., Martin, J. G.
(1997). Hyperpnea-induced bronchoconstriction is dependent on tachykinin-induced cysteinyl leukotriene synthesis. J. Appl. Physiol.
82: 538-544
[Abstract][Full Text]
Ahmed, T., Garrigo, J., Danta, I.
(1993). Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin. NEJM
329: 90-95
[Abstract][Full Text]
Weinberger, S. E.
(1993). Recent Advances in Pulmonary Medicine- First of Two Parts. NEJM
328: 1389-1397
[Full Text]
(1990). PROMISING NEW ANTI-ASTHMA DRUGS: LEUKOTRIENE INHIBITORS. JWatch General
1990: 2-2
[Full Text]
Kanaoka, Y., Maekawa, A., Penrose, J. F., Austen, K. F., Lam, B. K.
(2001). Attenuated Zymosan-induced Peritoneal Vascular Permeability and IgE-dependent Passive Cutaneous Anaphylaxis in Mice Lacking Leukotriene C4 Synthase. J. Biol. Chem.
276: 22608-22613
[Abstract][Full Text]
Maekawa, A., Kanaoka, Y., Lam, B. K., Austen, K. F.
(2001). Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc. Natl. Acad. Sci. USA
98: 2256-2261
[Abstract][Full Text]
Previous
